Yondelis 1 MG vials
Ended Awarded
- Contract number
- SPE2DB25FQ1G4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,197
Award facts
- Contract value 100% obligated
- $13,197.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,197.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Yondelis 1 mg vials, with completion scheduled for September 24, 2025. This non-set-aside competitive award was processed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, fulfills critical medical supply needs across the Defense Health System through its extensive portfolio of brand-name and generic medications, specialty drugs, and medical commodities.
This delivery order represents a routine transaction within AmerisourceBergen's substantial federal pharmaceutical distribution business supporting the Defense Logistics Agency's medical supply chain. As the prime contractor under the Pharmaceutical Prime Vendor Global Program, AmerisourceBergen serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent performance in competitively awarded contracts—ranging from modest orders to substantial procurements exceeding $45,000—demonstrates its capability to meet federal medical procurement standards through open competition and fixed-price delivery mechanisms.
Quick answers
Who was awarded contract SPE2DB25FQ1G4?
SPE2DB25FQ1G4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FQ1G4 worth?
The government has obligated $13,197 on SPE2DB25FQ1G4.
Is contract SPE2DB25FQ1G4 an order under another contract?
Yes. SPE2DB25FQ1G4 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ1G4 competed?
The extent of competition for SPE2DB25FQ1G4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award